| A Novel Method of Screening for Ovarian Cancer Using Gynecologic Fluids and Mucus (NCT01787656) | University of South Alabama | 2013-01-01 |
| Accelerating Gastrointestinal Recovery (NCT01704651) | Jamie N. Bakkum-Gamez | 2013-01-01 |
| A Pilot Test for Newly Developed Synoptic Operative Template for Ovarian Cancer (SOTOC): National Cancer Center - Peritoneal Carcinomatosis Index (NCT01823731) | National Cancer Center, Korea | 2013-01-01 |
| Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study (NCT01705288) | Masonic Cancer Center, University of Minnesota | 2013-01-01 |
| Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma (NCT01824615) | Cathay General Hospital | 2013-01-01 |
| Shanghai Ovarian Cancer and Family Care Project (NCT06118307) | Shanghai First Maternity and Infant Hospital | 2013-01-01 |
| Cabazitaxel in Platinum Refractory Ovarian Cancer (NCT01747239) | Vejle Hospital | 2013-01-01 |
| PDL1 in Ovarian High Grade Serous Carcinoma (NCT04507191) | Port Said University hospital | 2012-12-01 |
| 18F-CP18 Imaging Studies for Cancer Treatment With Birinapant (NCT01766622) | National Institutes of Health Clinical Center (CC) | 2012-11-30 |
| The Effects Of Yoga On Quality Of Life Among A Population Of Ovarian/ Fallopian Tube/ Primary Peritoneal Cancer Patients Receiving Chemotherapy: A Feasibility Study (NCT01743547) | Northwestern University | 2012-11-01 |
| Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status (NCT01690598) | Vejle Hospital | 2012-11-01 |
| Strength Training Study for Survivors of Breast and Gynecologic Cancer (NCT01709175) | Nova Scotia Health Authority | 2012-11-01 |
| Elecsys HE4 Chinese Reference Value Study (NCT01738269) | Chinese PLA General Hospital | 2012-11-01 |
| Oxford Ovarian Cancer Predict Chemotherapy Response 01 (NCT01770535) | University of Oxford | 2012-11-01 |
| Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE) (NCT01684878) | Hoffmann-La Roche | 2012-10-22 |
| A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer (NCT01715168) | Azaya Therapeutics, Inc. | 2012-10-01 |
| Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab (NCT01706120) | National Cancer Institute, Naples | 2012-10-01 |
| Sentinel Node Detection in Clinical Early Stage Ovarian Cancer (NCT01734746) | Maastricht University Medical Center | 2012-10-01 |
| Myocet ® - Carboplatine in Ovarian Cancer in Relapse, Sensitive to the Platinum (NCT01705158) | ARCAGY/ GINECO GROUP | 2012-10-01 |
| BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients (NCT01624493) | Hoosier Cancer Research Network | 2012-10-01 |
| Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer (NCT01744821) | Northwestern University | 2012-10-01 |
| Follow-up of Gynecological Cancer Patients, Their Needs and Expectations, A Cooperation Project (NCT01691144) | University of Oslo | 2012-09-01 |
| Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer (NCT01679483) | Asan Medical Center | 2012-09-01 |
| A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer (NCT01610206) | Linda R Duska | 2012-09-01 |
| Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer (NCT01623349) | Dana-Farber Cancer Institute | 2012-09-01 |
| SGI-110 in Combination With Carboplatin in Ovarian Cancer (NCT01696032) | Astex Pharmaceuticals, Inc. | 2012-09-01 |
| Diffusion-weighted Imaging Study in Cancer of the Ovary (NCT01505829) | Institute of Cancer Research, United Kingdom | 2012-08-01 |
| Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer (NCT01661868) | Dana-Farber Cancer Institute | 2012-08-01 |
| Comparison to Psychological, Medical and Emotional Influencing Communication and Achievement Factors to Oncogenetics Tests (NCT03889171) | University Hospital, Montpellier | 2012-08-01 |
| Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA) (NCT01584115) | Instituto de Investigação em Imunologia | 2012-07-01 |
| Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer (NCT01402271) | European Organisation for Research and Treatment of Cancer - EORTC | 2012-07-01 |
| Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy (NCT01601548) | Masonic Cancer Center, University of Minnesota | 2012-07-01 |
| Blood Test for Ovarian Cancer Associated Auto Antibodies (NCT01334437) | Eventus Diagnostics Ltd | 2012-06-01 |
| Vargatef in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian Cancer (NCT01583322) | ARCAGY/ GINECO GROUP | 2012-06-01 |
| Pilot Study Evaluating the Oncogramme: Analysis of Response to Induction Treatment of Patients With Breast or Ovarian Cancer. (NCT02910622) | University Hospital, Limoges | 2012-06-01 |
| Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis (NCT01441089) | National Cancer Institute (NCI) | 2012-05-21 |
| CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer (NCT01583686) | National Cancer Institute (NCI) | 2012-05-04 |
| Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ) (NCT01600573) | JSehouli | 2012-05-01 |
| Structural and Functional Imaging and Cognitive Functions in Ovarian Cancer (NCT01591772) | Memorial Sloan Kettering Cancer Center | 2012-04-24 |
| Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal Tumors (NCT01572467) | Children's Oncology Group | 2012-04-01 |
| Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer (NCT01580696) | COL George Peoples, MD, FACS | 2012-04-01 |
| Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer (NCT01982500) | Hellenic Oncology Research Group | 2012-03-01 |
| Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT01670799) | New Mexico Cancer Research Alliance | 2012-03-01 |
| Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer (NCT01535157) | South Plains Oncology Consortium | 2012-02-01 |
| DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal Cancer (NCT00603460) | University of Pennsylvania | 2012-01-01 |
| An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors (NCT01618136) | Eisai Limited | 2012-01-01 |
| Endocrine Disruptors and Life STILe in Breast Cancer Development (NCT05748353) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2012-01-01 |
| TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer (NCT01493505) | Amgen | 2012-01-01 |
| Intra-op Detection of Occult Ovarian Carcinoma Using a Folate-Alpha Receptor Specific Fluorescent Ligand (NCT01511055) | Mayo Clinic | 2012-01-01 |
| Prognostic Value of Her2neu and EGFR in Primary Ovarian High Grade Serous Carcinoma. (NCT04284631) | Port Said University hospital | 2012-01-01 |
| Evaluation of Prognostic Factors for Tubo-ovarian Cancer in France (NCT05204342) | University Hospital, Montpellier | 2012-01-01 |
| Treg, Th17 Cells, NKT in Epithelial Ovarian Tumor (NCT03779399) | Medical University of Lublin | 2011-12-01 |
| Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study (NCT01544049) | University of Washington | 2011-12-01 |
| Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer (NCT01416038) | ImmunoVaccine Technologies, Inc. (IMV Inc.) | 2011-12-01 |
| Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer (NCT01471483) | Memorial Sloan Kettering Cancer Center | 2011-11-08 |
| A Study of DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer (NCT01469793) | Genentech, Inc. | 2011-11-01 |
| Doxorubicin + BIBF 1120 in Patients for Ovarian Cancer (NCT01485874) | Hoosier Cancer Research Network | 2011-11-01 |
| A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II) (NCT01482715) | pharmaand GmbH | 2011-11-01 |
| Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression (NCT01433224) | Children's Oncology Group | 2011-10-01 |
| Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia (NCT01444456) | Amgen | 2011-10-01 |
| Hypodontia and Ovarian Cancer (NCT01470235) | University of Aarhus | 2011-09-01 |
| Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting (NCT01432015) | Gynecologic Oncology Associates | 2011-09-01 |
| A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers (NCT01521325) | Morphotek | 2011-09-01 |
| A Survivorship Care Plan for Gynaecological Cancer Patients (NCT01582906) | Royal Marsden NHS Foundation Trust | 2011-08-01 |
| A Study of Adavosertib (MK-1775) in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ovarian Tumors With the P53 Gene Mutation (MK-1775-004) (NCT01357161) | Merck Sharp & Dohme LLC | 2011-07-26 |
| Validation of a Nutrition Screening Tool (NCT01851928) | Royal Marsden NHS Foundation Trust | 2011-07-01 |
| Vaccine Therapy in Treating Patients With Metastatic Solid Tumors (NCT01376505) | Robert Wesolowski | 2011-06-21 |
| CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors (NCT01386502) | National Cancer Institute (NCI) | 2011-06-15 |
| Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids (NCT01256268) | H. Lee Moffitt Cancer Center and Research Institute | 2011-06-13 |
| Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer (NCT01358071) | AGC Biologics S.p.A. | 2011-06-01 |
| Patient Reported Symptoms in Ovarian Cancer (PRECISION) (NCT01422265) | Genentech, Inc. | 2011-06-01 |
| Safety and Pharmacokinetics of Intraoperative Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) With Cisplatin to Treat Platinum-sensitive Recurrent Ovarian Cancer (NCT01387399) | University Hospital, Bonn | 2011-06-01 |
| ICON8: Weekly Chemotherapy in Ovarian Cancer (NCT01654146) | Medical Research Council | 2011-06-01 |
| INOVATYON STUDY -International, Randomized Study in Patients With Ovarian Cancer (NCT01379989) | Mario Negri Institute for Pharmacological Research | 2011-06-01 |
| Pelvic Floor Disorders in Survivors of Gynecologic Malignancies (NCT01370122) | Abramson Cancer Center at Penn Medicine | 2011-05-01 |
| Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer (NCT01220154) | David O'Malley | 2011-04-28 |
| Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED) (NCT01170650) | Endocyte | 2011-04-22 |
| AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2) (NCT01281254) | Amgen | 2011-04-18 |
| Study of Circulating Tumoral DNA in Ovarian Cancer (NCT01350908) | Institut Curie | 2011-04-01 |
| A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck (NCT01059643) | Eli Lilly and Company | 2011-04-01 |
| ROGYcare: The Impact of a Cancer Survivorship Care Plan on Patient Reported Outcomes and Health Care Providers (NCT01185626) | Lonneke van de Poll-Franse | 2011-04-01 |
| Epidemiology of Ovarian Cancer in Taiwan (NCT01465750) | National Taiwan University Hospital | 2011-04-01 |
| A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT01312389) | Abramson Cancer Center at Penn Medicine | 2011-04-01 |
| Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer (NCT01137071) | Recepta Biopharma | 2011-04-01 |
| HYPAZ: Hypertension Induced by Pazopanib (NCT01392352) | Cambridge University Hospitals NHS Foundation Trust | 2011-04-01 |
| A Trial of FANG™ Vaccine for Participants With Ovarian Cancer (NCT01309230) | Gradalis, Inc. | 2011-03-08 |
| Saracatinib and Paclitaxel in Platinum-resistant Ovarian Cancer (NCT01196741) | University College, London | 2011-03-01 |
| Distinction Between Lung Cancer and Gynecological Cancers by Canine Scent Detection (NCT01383408) | Schillerhoehe Hospital | 2011-03-01 |
| Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers (NCT01237067) | National Cancer Institute (NCI) | 2011-02-07 |
| Panitumumab and Gemcitabine in Relapsed Ovarian Cancer (NCT01296035) | Women and Infants Hospital of Rhode Island | 2011-02-01 |
| Phase II ABT-888 With Cyclophosphamide (NCT01306032) | National Cancer Institute (NCI) | 2011-01-12 |
| Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Ovarian Cancer and Peritoneal Metastasis (NCT01242436) | Universitaire Ziekenhuizen KU Leuven | 2011-01-01 |
| Circulating Lymphatic Progenitor Cell and Lymph Node Metastasis (NCT01268956) | Hospital Universitari de Bellvitge | 2011-01-01 |
| Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer (NCT01131039) | Emory University | 2011-01-01 |
| Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive (NCT01262040) | Memorial Sloan Kettering Cancer Center | 2010-12-14 |
| A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer (NCT01239732) | Hoffmann-La Roche | 2010-12-01 |
| Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer (NCT01065441) | Michael Har-Noy | 2010-12-01 |
| Weekly Paclitaxel With or Without Pazopanib in Platinum Resistant or Refractory Ovarian Cancer (NCT01644825) | National Cancer Institute, Naples | 2010-12-01 |
| Prolonged Emend in a Study (NYU 03-67) of Oxaliplatin and Topotecan in Previously Treated Ovarian Cancer (NCT01017809) | NYU Langone Health | 2010-12-01 |
| Perioperative Morbidity in Gyneco-oncology According to the Procedure : Coelioscopy Versus Robot-assisted Coelioscopy (NCT01247779) | Centre Oscar Lambret | 2010-12-01 |